Calyx, a leading technology-enabled provider of Medical Imaging services and IRT/RTSM (Interactive Response Technology/Randomised Trial Supply Management) to drug developers, and Invicro, a next-generation quantitative imaging biomarker company and pre-eminent development partner to pharma sponsors, have agreed to combine their business. This complementary combination will create a new global leader in the provision of medical imaging solutions and development services to the clinical research community. The enlarged Group (“Group”) formed through this strategic combination will...